936691-31-5

Basic information

• Product Name: 2-bromo-4-({[tert-butyl(dimethyl)silyl]oxy}methyl)-1,3-thiazole
• Synonyms: 2-bromo-4-({[tert-butyl(dimethyl)silyl]oxy}methyl)-1,3-thiazole
• CAS NO: 936691-31-5
• Molecular Weight: 308.315
• Mol File: 936691-31-5.mol
• Article Data: 18

Chemical Properties

• CAS DataBase Reference: 2-bromo-4-({[tert-butyl(dimethyl)silyl]oxy}methyl)-1,3-thiazole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-4-({[tert-butyl(dimethyl)silyl]oxy}methyl)-1,3-thiazole(936691-31-5)
• EPA Substance Registry System: 2-bromo-4-({[tert-butyl(dimethyl)silyl]oxy}methyl)-1,3-thiazole(936691-31-5)

Safety Data

• Hazardous Substances Data: 936691-31-5(Hazardous Substances Data)

Upstream product

• 5198-88-9 2-bromothiazole-4-carboxylic Acid 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 5198-86-7 (2-bromo-1,3-thiazol-4-yl)methanol 
• 100367-77-9 ethyl 2-bromothiazole-4-carboxylate 

Relevant articles and documents

Design, Synthesis, and Cytotoxic Activity of New Tubulysin Analogues

Synthesis of tubulysin analogues, containing an N-methyl substituent on tubuvaline-amide together with the replacement of either the hydrophobic N-terminal N-methyl pipecolic acid (Mep) or at both N- and C- terminal peptides with available heteroaromatic

SULFONIMIDAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: (Formula AA) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

NLRP MODULATORS

In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.